Biomaterials used for tissue engineering applications must provide a structural support
for the tissue development and also actively interact with cells, promoting adhesion,
proliferation and differentiation. To achieve this goal, adhesion molecules may be used,
such as the tripeptide Arg-Gly-Asp (RGD). RGD was found to be the major functional
amino acid sequence responsible for cellular adhesion. This sequence can be used to elicit
specific cellular responses and it has been extensively demonstrated that RGD sequence
improves cell adhesion, spreading and proliferation in different materials. Chitosan and
chitin represent a family of biopolymers, made up of b(14)-linked N-acetyl-Dglucosamine
and D-glucosamine subunits. Due to their biodegradability and
biocompatibility, chitin and chitosan, are widely studied for biomedical applications.
A method based on the use of a human Carbohydrate-Binding Module, with affinity for
chitin, was tested as an alternative approach to the chemical grafting of bioactive
peptides. This approach would simultaneously allow the production of recombinant
peptides (alternatively to peptide synthesis) and provide a simple way for the specific and
strong adsorption of the peptides to the biomaterial. A fusion recombinant protein,
containing the RGD sequence fused to a human chitin-binding module (ChBM), was
expressed in E. coli. The adhesion of fibroblasts to reacetylated chitosan (RC) films was
the model system selected to analyse the properties of the obtained proteins. Thus, the
evaluation of cell attachment and proliferation on polystyrene surfaces and reacetylated
chitosan films, coated with the recombinant proteins, was performed using mouse
embryo fibroblasts 3T3. The results show that the recombinant proteins affect negatively
fibroblasts anchorage to the materials surface, inhibiting its adhesion and proliferation.
We also conclude that this negative effect is fundamentally due to the human chitinbinding
domain
